全文获取类型
收费全文 | 3051篇 |
免费 | 205篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 68篇 |
妇产科学 | 71篇 |
基础医学 | 369篇 |
口腔科学 | 82篇 |
临床医学 | 253篇 |
内科学 | 668篇 |
皮肤病学 | 86篇 |
神经病学 | 172篇 |
特种医学 | 57篇 |
外科学 | 509篇 |
综合类 | 74篇 |
一般理论 | 1篇 |
预防医学 | 265篇 |
眼科学 | 65篇 |
药学 | 330篇 |
中国医学 | 12篇 |
肿瘤学 | 164篇 |
出版年
2023年 | 44篇 |
2022年 | 87篇 |
2021年 | 168篇 |
2020年 | 95篇 |
2019年 | 127篇 |
2018年 | 150篇 |
2017年 | 102篇 |
2016年 | 102篇 |
2015年 | 92篇 |
2014年 | 153篇 |
2013年 | 150篇 |
2012年 | 193篇 |
2011年 | 231篇 |
2010年 | 169篇 |
2009年 | 108篇 |
2008年 | 128篇 |
2007年 | 149篇 |
2006年 | 125篇 |
2005年 | 135篇 |
2004年 | 108篇 |
2003年 | 113篇 |
2002年 | 77篇 |
2001年 | 48篇 |
2000年 | 28篇 |
1999年 | 25篇 |
1998年 | 11篇 |
1997年 | 19篇 |
1996年 | 7篇 |
1994年 | 9篇 |
1993年 | 13篇 |
1992年 | 25篇 |
1991年 | 27篇 |
1990年 | 14篇 |
1989年 | 17篇 |
1988年 | 17篇 |
1987年 | 7篇 |
1986年 | 19篇 |
1985年 | 13篇 |
1984年 | 9篇 |
1983年 | 10篇 |
1981年 | 7篇 |
1979年 | 11篇 |
1978年 | 7篇 |
1977年 | 12篇 |
1976年 | 9篇 |
1974年 | 8篇 |
1973年 | 16篇 |
1972年 | 18篇 |
1971年 | 11篇 |
1967年 | 6篇 |
排序方式: 共有3273条查询结果,搜索用时 16 毫秒
91.
92.
93.
94.
Toze CL Dalal CB Nevill TJ Gillan TL Abou Mourad YR Barnett MJ Broady RC Forrest DL Hogge DE Nantel SH Power MM Song KW Sutherland HJ Smith CA Narayanan S Young SS Connors JM Shepherd JD 《British journal of haematology》2012,158(2):174-185
The curative potential of allogeneic haematopoietic stem cell transplant (allo HSCT) in chronic lymphocytic leukaemia CLL is established, with a demonstrated role for graft-versus-leukaemia and less certainty for other factors in determining outcome. The first two decades of CLL patients proceeding to allo HSCT at the Leukaemia/Bone Marrow Transplant Program of British Columbia (n = 49 consecutive, 1991-2009) were studied to clarify factors predicting outcome. The donor was related in 29 (59%) and unrelated in 20 (41%). Conditioning was reduced-intensity in 27 (55%) and myeloablative in 22 (45%). Thirty-one of 49 patients survive with median follow-up of 5 years (0·2-15). Cumulative incidence of non-relapse mortality; complete remission (CR); clearance of fluorescence in situ hybridization (FISH) abnormality and progression at 10 years was 36%; 69%; 55% and 22%. Overall survival (OS) was 63% at 2 years; 55% at 5 years and beyond. Factors predicting OS (P value by log rank <0·05) were: comorbidity index <3, FISH rank (Dohner) and 17p deletion, alemtuzumab pre-HSCT, achievement of CR post-HSCT, donor chimerism >90%, clearance of FISH abnormality post-HSCT and absence of high-grade (3-4) graft-versus-host disease. Results from this province-wide, two-decade cohort demonstrated that a substantial proportion of patients with high-risk CLL become long term disease-free survivors. 相似文献
95.
96.
Reham Abou El Fadl Mai Gowely Muhammad Helmi Maram Obeid 《Acta odontologica Scandinavica》2013,71(7):552-558
Objective: To assess the effect of preoperative administration of ibuprofen and acetaminophen on the efficacy of buccal infiltration for pulp therapy in mandibular primary molars.Materials and methods: A randomized controlled trial with an ID no. NCT03423329 in Clinical-Trials.gov was conducted in the outpatient clinic of Paediatric Dentistry Department at Ain Shams University. The study was designed with two test arms where either ibuprofen or acetaminophen was administered to children whereas in the control arm a multivitamin placebo was used. Children's self-reported pain responses were recorded using Wong–Baker FACES pain scale. For statistical analysis, Chi-square test or Fisher’s exact test was used to compare between the three groups whereas Friedman’s test was used to study changes within each group.Results: In a sample of 60 children, a significant decrease in the mean pain rating scores was detected in all groups where success rates ranged from 40% with ibuprofen to 55% and 65% with acetaminophen and placebo, respectively. However, there was no statistically significant difference between the three groups regarding severity of pain during access cavity preparation.Conclusions: Both analgesics have no clinical advantage over the placebo in increasing the efficacy of buccal infiltration during pulp therapy in mandibular primary molars. 相似文献
97.
98.
H. Krichen Y. Gorgi T. Dhaouadi Y. Mecheri I. Sfar R. Bardi M.M. Bacha E. Abderrahim S. Jendoubi-Ayed K. Ayed T. Ben Abdallah 《Transplantation proceedings》2013,45(10):3472-3477
BackgroundAcute and chronic rejections remain an important cause of graft loss after renal transplantation. Currently, activation of innate immune responses through Toll-like receptors (TLRs) is suspected to be implied in the loss of the transplant tolerance.ObjectivesWe investigated functional single nucleotide polymorphisms (SNPs) of TLR4 and its coreceptor CD14 in kidney transplantation and looked for any potential role in acute rejection (AR) and chronic allograft nephropathy (CAN) and impact on graft survival.Patients and MethodsTLR4 (Asp299Gly) and CD14 (C/T -159) SNPs were detected using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 209 kidney transplant recipients (KTRs) including 132 treated with mycophenolate mofetil (MMF+). AR occurred in 59 patients and 24 were identified as having CAN by biopsy and scored according to the Banff criteria.ResultsThere were no significant associations between TLR4 and CD14 genotypes and alleles and the occurrence of both AR episodes and CAN. Moreover, TLR4 and CD14 SNPs did not seem to influence kidney graft survival. Analysis according to human leukocyte antigen (HLA) compatibility status, positivity of anti-HLA antibodies, and immunosuppression by MMF confirmed the absence of correlation of the investigated SNPs with the graft outcome. In addition, incidence of post-transplantation infections, including cytomegalovirus (CMV) infections, was not influenced by both TLR4 and CD14 SNPs.ConclusionThese results suggest that TLR4 (Asp299Gly) and CD14 (C/T -159) functional SNPs do not play a major role in AR, CAN, and kidney graft survival. Therefore, intragraft monitoring of TLR4/CD14 genes expression by messenger RNA (mRNA) would provide clarity on the exact role of these receptors in graft injuries. 相似文献
99.
100.
Kobeissy AA Hashash JG Jamali FR Skoury AM Haddad R El-Samad S Ladki R Aswad R Soweid AM 《World journal of gastroenterology : WJG》2012,18(19):2390-2395
AIM: To compare the efficacy of the proton-pump inhibitor, rabeprazole, with that of the H2-receptor antagonist, ranitidine, as on-demand therapy for relieving symptoms associated with non-erosive reflux disease (NERD).METHODS: This is a single center, prospective, randomized, open-label trial of on-demand therapy with rabeprazole (group A) vs ranitidine (group B) for 4 wk. Eighty-three patients who presented to the American University of Beirut Medical Center with persistent gastroesophageal reflux disease (GERD) symptoms and a normal upper gastrointestinal endoscopy were eligible for the study. Patients in group A (n = 44) were allowed a maximum rabeprazole dose of 20 mg twice daily, while those in group B (n = 39) were allowed a maximum ranitidine dose of 300 mg twice daily. Efficacy was assessed by patient evaluation of global symptom relief, scores of the SF-36 quality of life (QoL) questionnaires, total number of pills used, and number of medication-free days.RESULTS: Among the 83 patients who were enrolled in the study, 76 patients (40 in the rabeprazole group and 36 in the ranitidine group) completed the 4-wk trial. Baseline characteristics were comparable between both groups. After 4 wk, there was no significant difference in the subjective global symptom relief between the rabeprazole and the ranitidine groups (71.4% vs 65.4%, respectively; P = 0.9). There were no statistically significant differences between mean cumulative scores of the SF-36 QoL questionnaire for the two study groups (rabeprazole 22.40 ± 27.53 vs ranitidine 17.28 ± 37.06; P = 0.582). There was no significant difference in the mean number of pills used (rabeprazole 35.70 ± 29.75 vs ranitidine 32.86 ± 26.98; P = 0.66). There was also no statistically significant difference in the mean number of medication-free days between both groups.CONCLUSION: Rabeprazole has a comparable efficacy compared to ranitidine when given on-demand for the treatment of NERD. Both medications were associated with improved quality of life. 相似文献